GABA (γ-aminobutyric acid) stimulation of the metabotropic GABA
B
receptor results in prolonged inhibition of neurotransmission that is central to brain physiology
1
. GABA
B
belongs to the Family C of G protein-coupled receptors (GPCRs), which operate as dimers to relay synaptic neurotransmitter signals into a cellular response through the binding and activation of heterotrimeric G proteins
2
,
3
. GABA
B
, however, is unique in its function as an obligate heterodimer in which agonist binding and G protein activation take place on distinct subunits
4
,
5
. Here we show structures of heterodimeric and homodimeric full-length GABA
B
receptors. Complemented by cellular signaling assays and atomistic simulations, the structures reveal an essential role for the GABA
B
extracellular loop 2 (ECL2) in relaying structural transitions by ordering the linker connecting the extracellular ligand-binding domain to the transmembrane region. Furthermore, the ECL2 of both GABA
B
subunits caps and interacts with the hydrophilic head of a phospholipid occupying the extracellular half of the transmembrane domain, thereby providing a potentially crucial link between ligand binding and the receptor core that engages G protein. These results provide a starting framework to decipher mechanistic modes of signal transduction mediated by GABA
B
dimers and have important implications for rational drug design targeting these receptors.
Cryogenic electron microscopy (cryo-EM) has widened the field of structure-based drug discovery by allowing for routine determination of membrane protein structures previously intractable. However, despite representing one of the largest classes of therapeutic targets, most inactive-state G protein-coupled receptors (GPCRs) have remained .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.